Shopping Cart
Remove All
Your shopping cart is currently empty
Fluspirilene (R 6218) is a non-competitive L-type calcium channel antagonist (IC50: 0.03 μM).Fluspirilene is a long-acting antipsychotic compound used in the treatment of schizophrenia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $35 | In Stock | In Stock | |
| 5 mg | $81 | In Stock | In Stock | |
| 10 mg | $123 | In Stock | In Stock | |
| 25 mg | $222 | In Stock | In Stock | |
| 50 mg | $333 | In Stock | In Stock | |
| 100 mg | $493 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $85 | In Stock | In Stock |
| Description | Fluspirilene (R 6218) is a non-competitive L-type calcium channel antagonist (IC50: 0.03 μM).Fluspirilene is a long-acting antipsychotic compound used in the treatment of schizophrenia. |
| Targets&IC50 | Ca2+ channel, L-type:0.03 μM |
| In vitro | Fluspirilene (1.25, 2.5, and 5 μM) demonstrates the inhibition of proliferation of T98, U87, and all GSC lines, while Fluspirilene (2.5 and 5 μM) inhibits the proliferation of U251 and SNB19.[2] Fluspirilene decreases the viability and suppresses the sphere-forming of glioma stem cell lines in a dose-dependent manner.[2] |
| In vivo | Fluspirilene obviously prolongs the survival of the TGS04 mouse model. Mice treated with fluspirilene display a remarkable reduction in tumor size.[2] |
| Synonyms | Redeptin, R 6218 |
| Molecular Weight | 475.57 |
| Formula | C29H31F2N3O |
| Cas No. | 1841-19-6 |
| Smiles | Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1 |
| Relative Density. | 1.1634 g/cm3 (Estimated) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (63.08 mM), Sonication and heating to 60℃ are recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.21 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.